Selective Targeting of the KRAS G12C Mutant: Kicking KRAS When It's Down.
Two recent studies evaluated a small molecule that specifically binds to and inactivates the KRAS G12C mutant. The new findings argue that the perception that mutant KRAS is persistently frozen in its active GTP-bound form may not be accurate.